NFKB1 and cancer: Curcumin derivatives have shown therapeutic potential in the treatment of prostate cancer, primarily through modulation of key signaling pathways linked to factors such as NF-κB, EGFR, and MAPK, leading to the induction of apoptosis and inhibition of cancer cell proliferation (Structures IV, VII, Figure 1) [2,7].